EXPRESSION OF FoxP3 TRANSCRIPTION FACTOR IN BRONCHIAL ASTHMA
https://doi.org/10.15789/1563-0625-2016-4-373-378
Abstract
Forty-two patients with allergic bronchial asthma (ABA) forty persons with non-allergic bronchial asthma (NABA), and 47 healthy controls were involved into the study. Expression of FoxP3 mRNA was analyzed by RT-PCR. In patients with bronchial asthma (ABA and NABA) we have revealed a significant decrease in FoxP3 mRNA expression levels, in comparison with control group. The patients with severe BA exhibited lowest levels of the FoxP3 mRNA expression as compared with other groups.
We revealed a decreased FoxP3 mRNA expression in mononuclear cells from peripheral blood, and an increased IL-17 level in blood serum of patients with bronchial asthma. These results may be considered a manifestation of serious inflammatory process. Probably, the data may reflect a disregulated expression of FoxP3 transcription factor. Therefore, we may assume a key role of FoxP3 for regulation of inflammatory activity in bronchial asthma.
About the Authors
A. V. Eremeeva
First I. Pavlov State Medical University
Russian Federation
Senior Technician, M. Chernorutskyi Department of Hospital Therapy with a Course of Allergology and Immunology
Russian Federation
Senior Technician, M. Chernorutskyi Department of Hospital Therapy with a Course of Allergology and Immunology
L. N. Sorokina
First I. Pavlov State Medical University
Russian Federation
PhD, MD (Medicine), Professor, M. Chernorutskyi Department of Hospital Therapy with a Course of Allergology and Immunology
Russian Federation
PhD, MD (Medicine), Professor, M. Chernorutskyi Department of Hospital Therapy with a Course of Allergology and Immunology
V. N. Mineev
First I. Pavlov State Medical University
Russian Federation
Russian Federation
PhD, MD (Medicine), Professor, M. Chernorutskyi Department of Hospital Therapy with a Course of Allergology and Immunology,
198516, St. Petersburg-Petrodvorets, Sankt-Peterburgskiy pr., 56, apt 15
V. V. Lim
First I. Pavlov State Medical University
Russian Federation
PhD (Medicine), Senior Technician, M. Chernorutskyi Department of Hospital Therapy with a Course of Allergology and Immunology
Russian Federation
PhD (Medicine), Senior Technician, M. Chernorutskyi Department of Hospital Therapy with a Course of Allergology and Immunology
M. A. Nyoma
First I. Pavlov State Medical University
Russian Federation
PhD (Medicine), Assistant Professor, M. Chernorutskyi Department of Hospital Therapy with a Course of Allergology and Immunology
Russian Federation
PhD (Medicine), Assistant Professor, M. Chernorutskyi Department of Hospital Therapy with a Course of Allergology and Immunology
V. I. Trofimov
First I. Pavlov State Medical University
Russian Federation
PhD, MD (Medicine), Professor, Head, M. Chernorutskyi Department of Hospital Therapy with a Course of Allergology and Immunology
Russian Federation
PhD, MD (Medicine), Professor, Head, M. Chernorutskyi Department of Hospital Therapy with a Course of Allergology and Immunology
References
1. Al-Muhsen S., Letuve S., Vazquez-Tello A., Pureza M.A., Al-Jahdali H., Bahammam A.S., Hamid Q., Halwani R. Th17 cytokines induce pro-fibrotic cytokines release from human eosinophils. Respir. Res., 2013, Vol. 14, no. 1, p. 34.
2. Al-Ramli W., Préfontaine D., Chouiali F., Martin J.G., Olivenstein R., Lemière C., Hamid Q. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J. Allergy. Clin. Immunol., 2009, Vol. 123, no. 5, pp. 1185-1187.
3. Bacchetta R., Barzaghi F., Roncarolo M.G. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Ann N. Y. Acad. Sci. 2016, Vol. 25.
4. Dragon S., Rahman M.S., Yang J., Unruh H., Halayko A.J., Gounni A.S. IL-17 enhances IL-1beta-mediated CXCL-8 release from human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol., 2007, Vol. 292, no. 4, pp. 1023-1029.
5. Jiang H., Wu X., Zhu H., Xie Y., Tang S., Jiang Y. FOXP3+Treg/Th17 cell imbalance in lung tissues of mice with asthma . Int. J. Clin. Exp. Med., 2015, Vol. 8, no. 3, pp. 4158-4163. 6. Kawaguchi K., Suzuki E., Yamaguchi A., Yamamoto M., Morita S., Toi M. Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer. Breast Cancer, 2016, Vol. 4.
6. Kim do H., Sohn J.H., Park H.J., Lee J.H., Park J.W., Choi J.M. CpG Oligodeoxynucleotide Inhibits Cockroach-Induced Asthma via Induction of IFN-γ+ Th1 Cells or Foxp3+ Regulatory T Cells in the Lung. Allergy Asthma Immunol. Res., 2016, Vol. 8, no. 3, pp. 264-275.
7. Shim J.U., Rhee J.H., Jeong J.U., Koh Y.I. Flagellin Modulates the Function of Invariant NKT Cells From Patients With Asthma via Dendritic Cells. Allergy Asthma Immunol. Res., 2016, Vol. 8, no. 3, pp. 206-215. 9. Stelmaszczyk-Emmel A., Zawadzka-Krajewska A., Głodkowska-Mrówka E., Demkow U. FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy. J. Immunol. Res., 2015, Vol. 2015, p. 731381.
8. Tao B., Ruan G., Wang D., Li Y., Wang Z., Yin G. Imbalance of Peripheral Th17 and Regulatory T Cells in Children with Allergic Rhinitis and Bronchial Asthma. Iran J. Allergy Asthma Immunol., 2015, Vol. 14, no. 3, pp. 273-279.
9. Wan Y.Y., Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature, 2007, Vol. 445, no. 7129, pp. 766-770. 12. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., Shen Y., Du J., Rubtsov Y.P., Rudensky A.Y., Ziegler S.F., Littman D.R. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature, 2008, Vol. 453, no. 7192, pp. 236-240.
Review
For citations:
Eremeeva A.V., Sorokina L.N., Mineev V.N., Lim V.V., Nyoma M.A., Trofimov V.I. EXPRESSION OF FoxP3 TRANSCRIPTION FACTOR IN BRONCHIAL ASTHMA. Medical Immunology (Russia). 2016;18(4):373-378. (In Russ.) https://doi.org/10.15789/1563-0625-2016-4-373-378
Views:
964
Email this article 